PT966299E - Novas formulacoes orais de calcitonina - Google Patents

Novas formulacoes orais de calcitonina

Info

Publication number
PT966299E
PT966299E PT97950098T PT97950098T PT966299E PT 966299 E PT966299 E PT 966299E PT 97950098 T PT97950098 T PT 97950098T PT 97950098 T PT97950098 T PT 97950098T PT 966299 E PT966299 E PT 966299E
Authority
PT
Portugal
Prior art keywords
new oral
oral calcitonin
calcitonin formulations
formulations
new
Prior art date
Application number
PT97950098T
Other languages
English (en)
Inventor
Matteo Ghirri
Marco Zema
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Publication of PT966299E publication Critical patent/PT966299E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PT97950098T 1996-11-07 1997-11-05 Novas formulacoes orais de calcitonina PT966299E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9623205.3A GB9623205D0 (en) 1996-11-07 1996-11-07 Novel pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PT966299E true PT966299E (pt) 2003-06-30

Family

ID=10802593

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97950098T PT966299E (pt) 1996-11-07 1997-11-05 Novas formulacoes orais de calcitonina

Country Status (15)

Country Link
US (1) US6352974B1 (pt)
EP (1) EP0966299B1 (pt)
JP (1) JP2001511114A (pt)
AR (1) AR010554A1 (pt)
AT (1) ATE232397T1 (pt)
AU (1) AU5317598A (pt)
CA (1) CA2270927A1 (pt)
CO (1) CO4930284A1 (pt)
DE (1) DE69719083T2 (pt)
DK (1) DK0966299T3 (pt)
ES (1) ES2192704T3 (pt)
GB (1) GB9623205D0 (pt)
PT (1) PT966299E (pt)
WO (1) WO1998019697A2 (pt)
ZA (1) ZA9710006B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000054797A2 (en) 1999-03-17 2000-09-21 Novartis Ag Pharmaceutical compositions comprising tgf-beta
EP1276756A4 (en) * 2000-04-12 2004-06-09 Human Genome Sciences Inc ALBUMIN FUSION PROTEINS
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US7713932B2 (en) * 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
PL1651249T3 (pl) * 2003-07-23 2013-04-30 Novartis Ag Zastosowanie kalcytoniny w zapaleniu kości i stawów
US20060078622A1 (en) * 2004-08-13 2006-04-13 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US7581403B2 (en) * 2005-04-15 2009-09-01 Deeks Daniel H Energy storage arrangement
AU2006236006B2 (en) * 2006-04-13 2012-09-06 The University Of Queensland Cyclised a-conotoxin peptides
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US20090117180A1 (en) * 2007-02-20 2009-05-07 Giovanni Ortenzi Stable digestive enzyme compositions
SG186648A1 (en) * 2007-02-20 2013-01-30 Aptalis Pharma Ltd Stable digestive enzyme compositions
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
JP6043929B2 (ja) 2010-10-01 2016-12-14 アラガン ファーマシューティカルズ インターナショナル リミテッド 腸溶コーティングされた低力価パンクレリパーゼ製剤
EP2987499B1 (en) 2011-08-08 2019-05-08 Allergan Pharmaceuticals International Limited Method for dissolution testing of solid compositions containing digestive enzymes
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
JP2016537387A (ja) 2013-08-09 2016-12-01 アラガン ファーマシューティカルズ インターナショナル リミテッド 経腸投与に適した消化酵素組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
JP2514249B2 (ja) * 1989-05-23 1996-07-10 帝人株式会社 安定化されたカルシトニン類医薬組成物
DE4119140C2 (de) * 1991-06-11 1994-05-11 Merz & Co Gmbh & Co Poröser, in Körperflüssigkeiten und Sekreten löslicher, spongoider Formkörper, dessen Herstellung und Verwendung
JPH08225454A (ja) * 1995-02-23 1996-09-03 Chugai Pharmaceut Co Ltd マイクロスフェア製剤

Also Published As

Publication number Publication date
DE69719083T2 (de) 2003-12-18
DE69719083D1 (de) 2003-03-20
AR010554A1 (es) 2000-06-28
CO4930284A1 (es) 2000-06-27
EP0966299B1 (en) 2003-02-12
CA2270927A1 (en) 1998-05-14
AU5317598A (en) 1998-05-29
GB9623205D0 (en) 1997-01-08
DK0966299T3 (da) 2003-06-02
ATE232397T1 (de) 2003-02-15
EP0966299A2 (en) 1999-12-29
WO1998019697A2 (en) 1998-05-14
ES2192704T3 (es) 2003-10-16
US6352974B1 (en) 2002-03-05
ZA9710006B (en) 1999-06-05
WO1998019697A3 (en) 1998-07-16
JP2001511114A (ja) 2001-08-07

Similar Documents

Publication Publication Date Title
DE59800487D1 (de) Zahnärztliches Handstück
ID20233A (id) Komposisi oral
ID19097A (id) Komposisi-komposisi oral
DE69730863D1 (de) Zahnseide
FI973749A0 (fi) Suun kautta annosteltava 2-metyylitienobentsodiatsepiinivalmiste
IT236092Y1 (it) Spazzolino da denti
PT973527E (pt) Formulacoes de libertacao prolongada de claritromicina
BR9508844A (pt) Composição oral
MA24473A1 (fr) Formulations
PT966299E (pt) Novas formulacoes orais de calcitonina
BR9506536A (pt) Composição oral
HUP0100090A3 (en) Oral care composition
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
BR9705756A (pt) Escareador dentário
ATA113397A (de) Zahnärztliches handstück
DE69712211D1 (de) Zahnseide
DE69713171D1 (de) Mundpflegezubereitung
BR9510467A (pt) Composições orais
DE69828097D1 (de) Mundpflegezusammensetzung
ID20466A (id) Komposisi oral
BR9710110A (pt) Novas formulações de inseticidas
BR9510307A (pt) Composições orais
ATA56997A (de) Dentales handstück
DE69818638D1 (de) Zahnmedizinisches implantat
DE69521906D1 (de) Zahnhygiene - präparate